Antithrombotic Activities of Sotagliflozin vs. Empagliflozin

NCT06618976 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: Sotagliflozin
DRUG: Empagliflozin

Sponsor

Icahn School of Medicine at Mount Sinai